These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24324038)

  • 1. Office blood pressure, ambulatory blood pressure monitoring, and echocardiographic abnormalities in women with polycystic ovary syndrome: role of obesity and androgen excess.
    Luque-Ramírez M; Martí D; Fernández-Durán E; Alpañés M; Álvarez-Blasco F; Escobar-Morreale HF
    Hypertension; 2014 Mar; 63(3):624-9. PubMed ID: 24324038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome.
    Luque-Ramírez M; Alvarez-Blasco F; Mendieta-Azcona C; Botella-Carretero JI; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2141-8. PubMed ID: 17389696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome.
    Chen MJ; Yang WS; Yang JH; Chen CL; Ho HN; Yang YS
    Hypertension; 2007 Jun; 49(6):1442-7. PubMed ID: 17389259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure regulation and resting heart rate abnormalities in adolescent girls with polycystic ovary syndrome.
    Zachurzok-Buczynska A; Szydlowski L; Gawlik A; Wilk K; Malecka-Tendera E
    Fertil Steril; 2011 Dec; 96(6):1519-25. PubMed ID: 22032814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
    Meyer C; McGrath BP; Teede HJ
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperinsulinemia and obese phenotype differently influence blood pressure in young normotensive patients with polycystic ovary syndrome.
    Mioni R; Cà AD; Turra J; Azzolini S; Xamin N; Bleve L; Maffei P; Vettor R; Fallo F
    Endocrine; 2017 Feb; 55(2):625-634. PubMed ID: 27142411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS).
    Borruel S; Fernández-Durán E; Alpañés M; Martí D; Alvarez-Blasco F; Luque-Ramírez M; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1254-63. PubMed ID: 23386652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome.
    Alpañés M; Luque-Ramírez M; Martínez-García MÁ; Fernández-Durán E; Álvarez-Blasco F; Escobar-Morreale HF
    Fertil Steril; 2015 Mar; 103(3):795-801.e2. PubMed ID: 25585504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovary syndrome and obesity do not affect vascular parameters related to early atherosclerosis in young women without glucose metabolism disturbances, arterial hypertension and severe abnormalities of lipid profile.
    Barcellos CR; Lage SH; Rocha MP; Hayashida SA; Baracat EC; Romano A; Brito VN; Marcondes JA
    Gynecol Endocrinol; 2013 Apr; 29(4):370-4. PubMed ID: 23327607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between 24-hour ambulatory blood pressure measurement and selected biochemical and anthropometric parameters in women with polycystic ovary syndrome.
    Franik G; Bizoń A; Szynkaruk-Matusiak M; Osowska K; Dryś A; Olszanecka-Glinianowicz M; Madej P
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):3947-3954. PubMed ID: 34156673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP19 gene expression in subcutaneous adipose tissue is associated with blood pressure in women with polycystic ovary syndrome.
    Lecke SB; Morsch DM; Spritzer PM
    Steroids; 2011 Nov; 76(12):1383-8. PubMed ID: 21807013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype.
    Armeni E; Stamatelopoulos K; Rizos D; Georgiopoulos G; Kazani M; Kazani A; Kolyviras A; Stellos K; Panoulis K; Alexandrou A; Creatsa M; Papamichael C; Lambrinoudaki I
    J Hypertens; 2013 Oct; 31(10):1998-2004. PubMed ID: 24107731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T; Honour JW; Conway GS
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone-associated blood pressure dysregulation in women with androgen excess polycystic ovary syndrome.
    Stone T; Yanes Cardozo LL; Oluwatade TN; Leone CA; Burgos M; Okifo F; Pal L; Reckelhoff JF; Stachenfeld NS
    Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H232-H243. PubMed ID: 37327000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension in Reproductive-Aged Women With Polycystic Ovary Syndrome and Association With Obesity.
    Joham AE; Boyle JA; Zoungas S; Teede HJ
    Am J Hypertens; 2015 Jul; 28(7):847-51. PubMed ID: 25542625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?
    Holte J; Gennarelli G; Berne C; Bergh T; Lithell H
    Hum Reprod; 1996 Jan; 11(1):23-8. PubMed ID: 8671152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.